Pyxus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-06-2024
- Paid Up Capital ₹ 0.10 M
as on 29-06-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 27.98 Cr
as on 29-06-2024
- Revenue -24.45%
(FY 2023)
- Profit 65.15%
(FY 2023)
- Ebitda 2540.19%
(FY 2023)
- Net Worth 31.12%
(FY 2023)
- Total Assets 37.91%
(FY 2023)
About Pyxus Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹27.98 Cr.
Sanket Shah, Salam Ahjel, Ahemadabbas Balospura, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018PTC103565
- Company No.
103565
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pyxus Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abbasali Balospura  | Director | 01-Jan-2021 | Current |
| Sanket Shah | Director | 04-May-2022 | Current |
Salam Ahjel  | Director | 08-Aug-2018 | Current |
| Ahemadabbas Balospura | Director | 08-Aug-2018 | Current |
Financial Performance and Corporate Structure Insights of Pyxus Pharmaceuticals.
Pyxus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.45% decrease. The company also saw a substantial improvement in profitability, with a 65.15% increase in profit. The company's net worth Soared by an impressive increase of 31.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pyxus Pharmaceuticals?
In 2023, Pyxus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Joinhub Global Exports LlpActive 5 years 7 monthsSanket Shah, Ahemadabbas Balospura and 1 more are mutual person
- Joinhub Pharma LlpActive 4 years 9 months
Sanket Shah, Ahemadabbas Balospura and 1 more are mutual person
- Britanica Medicines & Medical Equipment Private LimitedActive 2 years 2 months
Sanket Shah and Ahemadabbas Balospura are mutual person
- Bhr5 Pharmaceuticals Private LimitedActive 2 years 18 days
Sanket Shah and Abbasali Balospura are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Sep 2023 | ₹27.98 Cr | Open |
How Many Employees Work at Pyxus Pharmaceuticals?
Unlock and access historical data on people associated with Pyxus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pyxus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pyxus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
